3.2 Equine Medicine, Surgery & Anesthesia

Equine Medicine, Surgery & Anesthesia

Therapeutic management of the horse involves a combination of medical therapy, specialized surgical intervention, and carefully managed anesthesia. Due to the unique physiology and size of the horse, standard veterinary procedures must be tailored to minimize complications such as post-anesthetic myopathy and exuberant granulation tissue.

Colic Management: Medical vs. Surgical Intervention

Colic is a general term for abdominal pain. Differentiating whether a horse requires medical management or immediate surgery is one of the most critical decisions an equine practitioner must make.

Medical Management of Colic

Medical therapy is appropriate for simple obstructions (such as spasmodic colic, gas distension, or mild pelvic flexure impactions) that do not compromise intestinal vasculature. Essential components include:

• Fluid Therapy: Dehydration and shock are corrected using intravenous fluids (e.g., Lactated Ringer's Solution). Enteral fluids administered via a nasogastric tube (water, electrolytes) are highly effective for rehydrating pelvic flexure impactions.
• Laxatives: Enteral administration of osmotic agents like magnesium sulfate (Epsom salts) or lubricants like mineral oil helps soften and dissolve impactions.
• Analgesia: The non-steroidal anti-inflammatory drug (NSAID) flunixin meglumine (1.1 mg/kg IV) is the gold standard for visceral pain control. Alpha-2 agonists like detomidine and opioids like butorphanol are added for short-term, intensive analgesia.

Surgical Intervention Criteria

Surgical colic indicates a strangulating obstruction, severe displacement, or intestinal rupture. Immediate referral and surgical intervention are indicated by:

• Unrelenting Pain: Pain that is refractory to administration of flunixin meglumine or potent sedatives (e.g., detomidine).
• Cardiovascular Deterioration: A heart rate exceeding 60–80 bpm, accompanied by congested/muddy mucous membranes and a CRT > 3 seconds.
• Gastric Reflux: Large volumes of net gastric reflux (>2–4 L) with an alkaline pH, suggesting a small intestinal obstruction.
• Abnormal Rectal Palpation: Distended loops of small intestine, colonic volvulus, or tense mesenteric bands.
• Abnormal Peritoneal Fluid: A serosanguinous, turbid sample with total protein > 3.0 g/dL, nucleated cell count > 10,000/µL, and lactate levels exceeding concurrent blood lactate.

---

Equine Anesthesia Protocols

Equine anesthesia carries a higher risk of morbidity and mortality compared to small animal anesthesia. The protocol must ensure a smooth induction, stable maintenance, and a controlled recovery.

Pre-Medication (Sedation and Analgesia)

Pre-medication is vital to calm the horse and reduce the dosage of induction and maintenance agents.

• Alpha-2 Agonists: Xylazine (0.5–1.1 mg/kg IV, short-acting, 20–30 minutes) or detomidine (10–20 µg/kg IV, longer-acting, 45–60 minutes) are the cornerstones. They provide profound sedation, muscle relaxation, and visceral analgesia. Side effects include bradycardia, second-degree AV block, and transient hypertension followed by hypotension.
• Opioids: Butorphanol (0.05–0.1 mg/kg IV) is commonly combined with alpha-2 agonists to provide synergistic analgesia. Opioids should never be administered alone to unsedated horses, as they can cause excitement, pacing, and head pressing.
• Phenothiazines: Acepromazine (0.02–0.05 mg/kg IV) provides mild tranquilization but no analgesia. It acts via dopamine and alpha-1 adrenergic receptor blockade, causing peripheral vasodilation and hypotension. It is contraindicated in dehydrated/shocked horses. In stallions, it carries a small but significant risk of causing penile paralysis (priapism or paraphimosis).

Induction

Induction must transition the horse from standing to recumbent as rapidly and smoothly as possible to avoid orthopedic or soft tissue injury.

• Standard Protocol: Ketamine (2.2 mg/kg IV) combined with a benzodiazepine like diazepam or midazolam (0.05–0.1 mg/kg IV).
• Critical Requirement: The horse must show profound sedation (head down, dropping ears, relaxed lower lip) from the alpha-2 agonist before ketamine is administered. If ketamine is given to an inadequately sedated horse, it will cause muscle rigidity, excitation, and a dangerous, uncoordinated collapse.

Maintenance

• Total Intravenous Anesthesia (TIVA): Used for field procedures lasting less than 45–60 minutes (e.g., castrations). The most common protocol is the triple drip, a mixture of 5% guaifenesin (a centrally acting muscle relaxant), ketamine (1–2 mg/mL), and xylazine (0.5–1 mg/mL), infused intravenously to effect.
• Inhalation Anesthesia: Used for longer, invasive procedures. Isoflurane or sevoflurane is vaporized in oxygen and delivered via a large-animal circle circuit.

Anesthetic Monitoring and Complications

• Hypotension: Defined as a Mean Arterial Pressure (MAP) < 70 mmHg. This is a common and severe complication of inhalant anesthesia due to dose-dependent myocardial depression and vasodilation. Low perfusion pressure leads to post-anesthetic myopathy (ischemic muscle necrosis) and neuropathies (facial and radial nerve paralysis). MAP must be kept > 70 mmHg using positive inotropes (e.g., dobutamine infusion), fluid support, and lowering inhalant concentration.
• Hypoxemia: Defined as arterial partial pressure of oxygen (PaO2) < 60 mmHg. Caused by compression of the dependent lung tissue under the horse's weight, leading to ventilation-perfusion (V/Q) mismatch and atelectasis. Managed by mechanical ventilation and positive end-expiratory pressure (PEEP).
• Recovery: The most hazardous phase. Recovery stalls must be padded and quiet. Low-dose sedatives (e.g., xylazine) are often administered as the horse wakes up to prevent premature, uncoordinated attempts to stand. Supplemental intranasal oxygen is maintained.

---

Wound Management & Second Intention Healing

Wounds on the distal limbs of horses are notorious for slow healing and complications.

Second Intention Healing

When primary closure is not possible due to severe contamination, tension, or significant tissue loss, wounds are allowed to heal by second intention healing. This process relies on three sequential phases:

1. Inflammatory phase: Debridement of necrotic tissue.
2. Proliferative phase: Formation of healthy granulation tissue and contraction of wound margins.
3. Epithelialization phase: Migration of new skin cells across the granulation bed.

Exuberant Granulation Tissue (Proud Flesh)

In the distal limbs of horses, the proliferative phase often becomes dysregulated, leading to exuberant granulation tissue (proud flesh). This overgrowth rises above the skin margins and physically blocks epithelialization. It is driven by poor vascular supply, constant movement, minimal soft tissue padding, and persistent low-grade inflammation.

Management of Proud Flesh

• Surgical Debridement: The excess tissue must be excised down to or slightly below the level of the skin margins. Because granulation tissue contains no sensory nerves, debridement can be performed without local anesthesia. However, it is highly vascularized and requires pressure bandaging to control profuse hemorrhage.
• Topical Corticosteroids: Applied under bandages to suppress further fibroplasia and inflammatory cytokine release.
• Pressure Bandaging: Restricts tissue proliferation and protects the wound bed from environmental debris.
• Skin Grafting: Used for large wounds to accelerate epithelialization once a flat, healthy bed of granulation tissue is established.